Doctors may soon be able to tell just how sick a heart failure patient really is by using a routine MRI scan, thanks to new ...

The CHARM program consisted of 3 component trials, each comparing candesartan with placebo in a distinct population of patients with symptomatic heart failure [9]: CHARM-Alternative: patients with ...

A substudy of the CHARM trial (see Trial Glossary below for expansion of all trial names mentioned in this article) has shown that the angiotensin receptor blocker (ARB) candesartan reduces the risk ...

Please provide your email address to receive an email when new articles are posted on . CAD was significantly prognostic of all-cause mortality in patients with heart failure. Mortality risk was ...

Late-stage failure of the left side of the heart is an often-fatal condition affecting hundreds of thousands of people in the U.S. alone. A mechanical heart pump can be a lifesaving intervention for ...

Huawei is pushing the boundaries of smartwatch heart health tracking with a significant firmware update for the Watch ...

When the heart's muscle is weakened or injured due to a heart attack, it can make it hard for the heart to pump enough blood to meet the body's needs ...

Non-DNMT3A CHIP subtypes are associated with a higher incidence of heart failure compared to DNMT3A CHIP carriers. Significant associations with heart failure were found for most CHIP subtypes, except ...